Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers

Overview

About this study

This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Exclusion criteria for controls:

  • Patients with history of esophagectomy or mucosal ablation, gastric fundoplication or other gastric surgery, or known non-Barrett's esophageal pathology (e.g. eosinophilic esophagitis or achalasia) will be excluded.
  • Patients with prior history of colon polyps or colon/esophageal/gastric/pancreatic carcinoma (unless had negative colonoscopy within 2 years to clear polyps).
  • Control patients without endoscopic evidence of Barrett's will be frequency matched by age (± 5 years) and gender (similar distribution) to cases. To ensure similar age and gender distribution between cases and controls, monitoring of recruited cases and controls age and gender distribution will be performed every two weeks. Data on height, weight, smoking history, medications (NSAIDS, PPIs) and indications (as well as findings on endoscopy) for endoscopy will be abstracted from medical records. All participants will be >18 years of age and will provide informed consent.

Exclusion criteria for cases:

  • Patients with history of esophagectomy or mucosal ablation, gastric fundoplication or other gastric surgery, or known non-Barrett's esophageal pathology (e.g. eosinophilic esophagitis or achalasia) will be excluded.
  • Patients with prior history of colon polyps or colon/gastric/pancreatic carcinoma (unless had negative colonoscopy within 2 years to clear polyps).
  • Patients with esophageal varices or esophagitis LA Grade B,C, or D

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Prasad Iyer, M.D.

Closed for enrollment

Contact information:

Michele Johnson P.T.A., CCRP

(507)255-8692

johnson.michele@mayo.edu

More information

Publications

Publications are currently not available